...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study
【24h】

Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study

机译:癌症家族史和小儿及青少年霍奇金淋巴瘤的风险:儿童肿瘤小组研究

获取原文
获取原文并翻译 | 示例

摘要

Family history of lymphoid neoplasm (LN) is a strong and consistently observed Hodgkin lymphoma (HL) risk factor, although it has been only marginally examined in pediatric/adolescent patients. Here, healthy control children identified by random digit dialing were matched on sex, race/ethnicity and age to HL cases diagnosed at 0-14 years at Children's Oncology Group institutions in 1989-2003. Detailed histories were captured by structured telephone interviews with parents of 517 cases and 783 controls. Epstein-Barr virus (EBV) RNA detection was performed for 355 available case tumors. Two analytic strategies were applied to estimate associations between family cancer history and pediatric/adolescent HL. In a standard case-control approach, multivariate conditional logistic regression was used to calculate odds ratios and 95% confidence intervals (CIs). In a reconstructed cohort approach, each relative was included as a separate observation, and multivariate proportional hazards regression was used to produce hazard ratios (HRs) and 95% CIs. Using the latter, pediatric/adolescent HL was associated with a positive family history (HR = 1.20, 95% CI: 1.06-1.36), particularly early-onset cancers (HR = 1.30, 95% CI: 1.06-1.59) and those in the paternal lineage (HR = 1.38, 95% CI: 1.16-1.65), with a suggested association for LN in first-degree relatives (HR = 3.61, 95% CI: 0.87-15.01). There were no discernable patterns for EBV+ versus EBV- HL. The clustering of LN within pedigrees may signal shared genetic susceptibility or common environmental exposures. Heritable genetic risk variants have only recently begun to be discovered, however. These results are consistent with other studies and provide a compelling rationale for family-based studies to garner information about genetic susceptibility to HL.
机译:淋巴瘤家族史(LN)是一个强有力且持续观察到的霍奇金淋巴瘤(HL)危险因素,尽管仅在儿科/青少年患者中进行了少量检查。在这里,将通过随机数字拨号识别的健康对照儿童的性别,种族/民族和年龄与1989-2003年在儿童肿瘤学组机构诊断为0-14岁的HL病例相匹配。通过对517例病例和783例对照的父母进行的结构性电话访谈,记录了详细的历史记录。对355种可用病例肿瘤进行了爱泼斯坦-巴尔病毒(EBV)RNA检测。应用了两种分析策略来估计家族癌症史与小儿/青少年HL之间的关联。在标准病例对照方法中,多元条件逻辑回归用于计算比值比和95%置信区间(CI)。在重构的队列研究方法中,每个亲戚都作为一个单独的观察对象包括在内,并使用多元比例风险回归来产生风险比(HRs)和95%CI。使用后者,小儿/青少年HL与阳性家族史(HR = 1.20,95%CI:1.06-1.36)相关,尤其是早发性癌症(HR = 1.30,95%CI:1.06-1.59),而在父系(HR = 1.38,95%CI:1.16-1.65),并与一级亲属的LN相关(HR = 3.61,95%CI:0.87-15.01)。 EBV +与EBV-HL没有明显的区别。 LN在谱系中的聚集可能表明存在共同的遗传易感性或常见的环境暴露。但是,可遗传的遗传风险变体只是最近才被发现。这些结果与其他研究一致,并且为基于家庭的研究提供了令人信服的理由,以收集有关HL遗传易感性的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号